Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Naïve B-cell receptors specific for pneumococcal capsular polysaccharide (PPS) epitopes are membrane-bound immunoglobulins expressed on the surface of B lymphocytes that have not yet encountered their specific antigen. These receptors are the primary sensors for the complex carbohydrate capsules of Streptococcus pneumoniae, which are critical for bacterial virulence and immune evasion (Clutterbuck et al., 2012, PubMed: 22302121). Upon binding to PPS epitopes, these receptors initiate intracellular signaling cascades that drive B-cell activation, proliferation, and differentiation into antibody-secreting plasma cells (Janeway et al., 2001, Immunobiology). In clinical practice, these receptors are the targets of pneumococcal vaccines; pure polysaccharide vaccines (e.g., PPSV23) act by cross-linking these receptors to induce a T-cell independent response, while conjugate vaccines (e.g., PCV13, PCV20) utilize protein carriers to engage T-cell help (Pollard et al., 2009, Nature Reviews Immunology). The effectiveness of these vaccines depends on the ability of the naïve BCR repertoire to recognize diverse serotypes and transition into high-affinity memory B cells. Understanding the interaction between these receptors and various polysaccharide structures is vital for addressing challenges such as serotype replacement and age-related immunosenescence (CDC, 2023).
Antigen-mediated cross-linking of B-cell receptors on naïve B cells, which triggers the Ig-alpha/Ig-beta signaling complex, leading to B-cell activation, proliferation, and differentiation into antibody-secreting plasma cells.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Naïve B-cell receptor specific for pneumococcal capsular polysaccharide epitopes (PPS-specific BCR).